The Marwood Group, a health care-focused consulting firm co-founded by Kennedy, received notice from the Securities and Exchange Commission this week that the agency’s staff plans to recommend charging the company with civil insider trading, Fox Business Network reported Tuesday. The investigation has focused on alleged government information passed on to Marwood clients in 2010 about a new prostate-cancer treatment.

Click here to read original article